HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$1.08
Day range
$1.04 - $1.17
Year range
$0.80 - $3.19
Market cap
46.84M USD
Avg Volume
35.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.59M | -6.24% |
Net income | -2.46M | 9.36% |
Net profit margin | — | — |
Earnings per share | -0.09 | 18.18% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.00M | 125.73% |
Total assets | 15.84M | 111.19% |
Total liabilities | 878.80K | -13.30% |
Total equity | 14.96M | — |
Shares outstanding | 41.08M | — |
Price to book | 3.00 | — |
Return on assets | -70.68% | — |
Return on capital | -76.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.46M | 9.36% |
Cash from operations | -1.41M | 22.49% |
Cash from investing | — | — |
Cash from financing | 15.00M | 24,156.20% |
Net change in cash | 13.59M | 824.62% |
Free cash flow | -560.02K | 33.45% |
About
Founded
2020
Headquarters
Website
Employees
3
